Shuai Ding et al., published a scientific review article in the International Journal of Molecular Science that explores the applications of the CRISPR/Cas9 gene editing system in cancer therapy. The review focuses on three primary applications: CRISPR-based CAR-T cell therapy, CRISPR screening techniques for identifying new drug targets and cancer-related genes, and the use of CRISPR for generating cancer models in vitro and in vivo. The authors discuss the CRISPR/Cas9 system's mechanism, its advantages over other gene editing technologies, and its potential benefits for cancer treatment. However, the review also acknowledges the challenges associated with CRISPR/Cas9 technology, including off-target effects, delivery issues, and the potential risk of carcinogenesis. The article highlights the ongoing research efforts to address these challenges and further refine this promising tool for combating cancer.

Ver todos los episodios